Terms: = Endocrine gland cancer AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18 AND Prognosis
30 results:
1. FBXO28 promotes cell proliferation, migration and invasion via upregulation of the TGF-beta1/smad2/3 signaling pathway in ovarian cancer.
Song G; Sun Z; Chu M; Zhang Z; Chen J; Wang Z; Zhu X
BMC Cancer; 2024 Jan; 24(1):122. PubMed ID: 38267923
[TBL] [Abstract] [Full Text] [Related]
2. Correlations between the expression of molecules in the TGF-β signaling pathway and clinical factors in adamantinomatous craniopharyngiomas.
Jin L; Cai K; Wu W; Xiao Y; Qiao N; Liu F; Ru S; Cao L; Zhu H; Bai J; Liu C; Li C; Zhao P; Zhang Y; Gui S
Front Endocrinol (Lausanne); 2023; 14():1167776. PubMed ID: 37854185
[TBL] [Abstract] [Full Text] [Related]
3. BRD9-smad2/3 Orchestrates Stemness and Tumorigenesis in Pancreatic Ductal Adenocarcinoma.
Feng Y; Cai L; Pook M; Liu F; Chang CH; Mouti MA; Nibhani R; Militi S; Dunford J; Philpott M; Fan Y; Fan GC; Liu Q; Qi J; Wang C; Hong W; Morgan H; Wang M; Sadayappan S; Jegga AG; Oppermann U; Wang Y; Huang W; Jiang L; Pauklin S
Gastroenterology; 2024 Jan; 166(1):139-154. PubMed ID: 37739089
[TBL] [Abstract] [Full Text] [Related]
4. STAT3 inhibition enhances gemcitabine sensitivity in pancreatic cancer by suppressing EMT, immune escape and inducing oxidative stress damage.
Guo H; Hu Z; Yang X; Yuan Z; Gao Y; Chen J; Xie L; Chen C; Guo Y; Bai Y
Int Immunopharmacol; 2023 Oct; 123():110709. PubMed ID: 37515849
[TBL] [Abstract] [Full Text] [Related]
5. Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Preclinical Models for Treatment Response.
Braun R; Lapshyna O; Watzelt J; Drenckhan M; Künstner A; Färber B; Hael AAM; Bolm L; Honselmann KC; Konukiewitz B; Castven D; Spielmann M; Gorantla SP; Busch H; Marquardt JU; Keck T; Wellner UF; Ungefroren H
Cells; 2023 Feb; 12(4):. PubMed ID: 36831254
[TBL] [Abstract] [Full Text] [Related]
6. smad2/3 mediate oncogenic effects of TGF-β in the absence of SMAD4.
Bertrand-Chapel A; Caligaris C; Fenouil T; Savary C; Aires S; Martel S; Huchedé P; Chassot C; Chauvet V; Cardot-Ruffino V; Morel AP; Subtil F; Mohkam K; Mabrut JY; Tonon L; Viari A; Cassier P; Hervieu V; Castets M; Mauviel A; Sentis S; Bartholin L
Commun Biol; 2022 Oct; 5(1):1068. PubMed ID: 36207615
[TBL] [Abstract] [Full Text] [Related]
7. The miR-33a-5p/CROT axis mediates ovarian cancer cell behaviors and chemoresistance
Li X; Gao X; Yuan J; Wang F; Xu X; Wang C; Liu H; Guan W; Zhang J; Xu G
Front Endocrinol (Lausanne); 2022; 13():950345. PubMed ID: 36120434
[TBL] [Abstract] [Full Text] [Related]
8. Transforming growth factor-β challenge alters the N-, O-, and glycosphingolipid glycomes in PaTu-S pancreatic adenocarcinoma cells.
Zhang J; Zhang Z; Holst S; Blöchl C; Madunic K; Wuhrer M; Ten Dijke P; Zhang T
J Biol Chem; 2022 Mar; 298(3):101717. PubMed ID: 35151689
[TBL] [Abstract] [Full Text] [Related]
9. Tumor-stroma TGF-β1-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin α
Nan P; Dong X; Bai X; Lu H; Liu F; Sun Y; Zhao X
Cancer Lett; 2022 Mar; 528():59-75. PubMed ID: 34958892
[TBL] [Abstract] [Full Text] [Related]
10. LncRNA PVT1 promotes the progression of ovarian cancer by activating TGF-β pathway via miR-148a-3p/AGO1 axis.
Wu Y; Gu W; Han X; Jin Z
J Cell Mol Med; 2021 Sep; 25(17):8229-8243. PubMed ID: 34288373
[TBL] [Abstract] [Full Text] [Related]
11. SCRIB Is Involved in the Progression of Ovarian Carcinomas in Association with the Factors Linked to Epithelial-to-Mesenchymal Transition and Predicts Shorter Survival of Diagnosed Patients.
Hussein UK; Ahmed AG; Choi WK; Kim KM; Park SH; Park HS; Noh SJ; Lee H; Chung MJ; Moon WS; Kang MJ; Cho DH; Jang KY
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33803371
[TBL] [Abstract] [Full Text] [Related]
12. cancer-associated fibroblasts-mediated ATF4 expression promotes malignancy and gemcitabine resistance in pancreatic cancer via the TGF-β1/smad2/3 pathway and ABCC1 transactivation.
Wei L; Lin Q; Lu Y; Li G; Huang L; Fu Z; Chen R; Zhou Q
Cell Death Dis; 2021 Mar; 12(4):334. PubMed ID: 33782384
[TBL] [Abstract] [Full Text] [Related]
13. KRT7 promotes epithelial‑mesenchymal transition in ovarian cancer via the TGF‑β/smad2/3 signaling pathway.
An Q; Liu T; Wang MY; Yang YJ; Zhang ZD; Liu ZJ; Yang B
Oncol Rep; 2021 Feb; 45(2):481-492. PubMed ID: 33416175
[TBL] [Abstract] [Full Text] [Related]
14. Quercetin suppresses pancreatic ductal adenocarcinoma progression via inhibition of SHH and TGF-β/Smad signaling pathways.
Guo Y; Tong Y; Zhu H; Xiao Y; Guo H; Shang L; Zheng W; Ma S; Liu X; Bai Y
Cell Biol Toxicol; 2021 Jun; 37(3):479-496. PubMed ID: 33070227
[TBL] [Abstract] [Full Text] [Related]
15. Nucleosome Assembly Protein 1-Like 3 Enhances Cisplatin Resistance of Ovarian cancer Cell by Activating Transforming Growth Factor-Beta Pathway.
Mo X; Sun J; Xu L; Zhao N; Yan M; Li H; Qin P
J Interferon Cytokine Res; 2020 Jul; 40(7):333-340. PubMed ID: 32701410
[TBL] [Abstract] [Full Text] [Related]
16. Establishment of a 7-miRNA-Based Risk Score System for Predicting prognosis of Pancreatic cancer.
Zhuang H; Ma Z; Huang K; Zhou Z; Huang B; Sun Z; Hou B; Zhang C
Pancreas; 2020; 49(5):655-662. PubMed ID: 32433403
[TBL] [Abstract] [Full Text] [Related]
17. TGF-β1 secreted by pancreatic stellate cells promotes stemness and tumourigenicity in pancreatic cancer cells through L1CAM downregulation.
Cave DD; Di Guida M; Costa V; Sevillano M; Ferrante L; Heeschen C; Corona M; Cucciardi A; Lonardo E
Oncogene; 2020 May; 39(21):4271-4285. PubMed ID: 32291413
[TBL] [Abstract] [Full Text] [Related]
18. Effects of ME3 on the proliferation, invasion and metastasis of pancreatic cancer cells through epithelial-mesenchymal transition.
Zhang Q; Li J; Tan XP; Zhao Q
Neoplasma; 2019 Nov; 66(6):896-907. PubMed ID: 31607129
[TBL] [Abstract] [Full Text] [Related]
19. Macrophage-expressed CD51 promotes cancer stem cell properties via the TGF-β1/smad2/3 axis in pancreatic cancer.
Zhang B; Ye H; Ren X; Zheng S; Zhou Q; Chen C; Lin Q; Li G; Wei L; Fu Z; Zhang Y; Hu C; Li Z; Chen R
Cancer Lett; 2019 Sep; 459():204-215. PubMed ID: 31199988
[TBL] [Abstract] [Full Text] [Related]
20. LncRNA SPRY4-IT was concerned with the poor prognosis and contributed to the progression of thyroid cancer.
Zhou H; Sun Z; Li S; Wang X; Zhou X
Cancer Gene Ther; 2018 Feb; 25(1-2):39-46. PubMed ID: 29234152
[TBL] [Abstract] [Full Text] [Related]
[Next]
